# TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma

> **NCT00556803** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 120 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cancer

## Interventions

- **PROCEDURE:** radiofrequency ablation
- **PROCEDURE:** TACE after RFA

## Key facts

- **NCT ID:** NCT00556803
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2008-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556803, "TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00556803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*